Hartford Funds Management Co LLC acquired a new stake in shares of Humana Inc. (NYSE:HUM – Free Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 2,417 shares of the insurance provider’s stock, valued at approximately $419,000.
Other institutional investors have also modified their holdings of the company. Calamos Wealth Management LLC purchased a new position in Humana in the 1st quarter valued at about $301,000. Calamos Advisors LLC boosted its holdings in Humana by 4.9% in the 1st quarter. Calamos Advisors LLC now owns 37,245 shares of the insurance provider’s stock worth $6,458,000 after buying an additional 1,735 shares during the last quarter. AMF Tjanstepension AB increased its stake in Humana by 2.9% during the 1st quarter. AMF Tjanstepension AB now owns 155,989 shares of the insurance provider’s stock worth $27,047,000 after buying an additional 4,433 shares in the last quarter. J. Safra Sarasin Holding AG raised its holdings in shares of Humana by 41.0% during the first quarter. J. Safra Sarasin Holding AG now owns 4,773 shares of the insurance provider’s stock valued at $827,000 after acquiring an additional 1,389 shares during the last quarter. Finally, Global Assets Advisory LLC purchased a new position in shares of Humana in the first quarter valued at approximately $38,000. Institutional investors and hedge funds own 92.38% of the company’s stock.
Humana Stock Performance
Shares of Humana stock opened at $405.81 on Tuesday. Humana Inc. has a one year low of $163.11 and a one year high of $415.00. The company has a market cap of $48.72 billion, a price-to-earnings ratio of 43.40, a PEG ratio of 2.24 and a beta of 0.71. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.77 and a current ratio of 1.77. The business’s 50 day moving average price is $342.18 and its 200 day moving average price is $256.22.
Humana Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be issued a $0.885 dividend. The ex-dividend date of this dividend is Friday, June 26th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 0.9%. Humana’s dividend payout ratio is currently 37.86%.
Analyst Upgrades and Downgrades
A number of brokerages have recently issued reports on HUM. The Goldman Sachs Group lifted their price target on Humana from $158.00 to $195.00 and gave the stock a “sell” rating in a research note on Thursday, April 30th. Oppenheimer raised Humana from an “outperform” rating to an “outperform” rating in a research note on Wednesday, May 20th. Robert W. Baird decreased their price objective on Humana from $264.00 to $205.00 and set a “neutral” rating on the stock in a report on Wednesday, April 15th. Sanford C. Bernstein reaffirmed an “outperform” rating and set a $425.00 target price on shares of Humana in a research note on Wednesday, June 3rd. Finally, Bank of America upped their target price on shares of Humana from $340.00 to $380.00 and gave the stock a “neutral” rating in a report on Wednesday, June 24th. One research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, sixteen have given a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $315.70.
Check Out Our Latest Stock Report on Humana
Humana Profile
Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.
In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.
Featured Articles
- Five stocks we like better than Humana
- The SK Hynix IPO and 2027’s AI Memory Squeeze
- Meta Platforms Stock Rises as Muse Spark 1.1 AI Model Debuts
- Why Welltower’s Growth Story Might Outrun Its Rich Valuation
- One Short- and One Long-Term ETF for Quantum Computing Bulls
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
